Despite all his rhetoric playing down the virus, Trump knew a vaccine before the election could help him politically. Pfizer’s chief executive Albert Bourla joined the chorus of voices in the scientific community trying to shift the president’s tactics and tone. “Once more, I was disappointed that the prevention for a deadly disease was discussed in political terms rather than scientific facts,” Bourla said in an open letter to colleagues.
